EA200801475A1 - Полипептидные маркеры для диагностики и оценки сосудистых заболеваний - Google Patents

Полипептидные маркеры для диагностики и оценки сосудистых заболеваний

Info

Publication number
EA200801475A1
EA200801475A1 EA200801475A EA200801475A EA200801475A1 EA 200801475 A1 EA200801475 A1 EA 200801475A1 EA 200801475 A EA200801475 A EA 200801475A EA 200801475 A EA200801475 A EA 200801475A EA 200801475 A1 EA200801475 A1 EA 200801475A1
Authority
EA
Eurasian Patent Office
Prior art keywords
markers
vascular diseases
polypeptid
diagnostics
evaluation
Prior art date
Application number
EA200801475A
Other languages
English (en)
Other versions
EA014529B1 (ru
Inventor
Харальд Мишак
Original Assignee
Мозаикс Дайогностикс Энд Терапьютикс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мозаикс Дайогностикс Энд Терапьютикс Аг filed Critical Мозаикс Дайогностикс Энд Терапьютикс Аг
Publication of EA200801475A1 publication Critical patent/EA200801475A1/ru
Publication of EA014529B1 publication Critical patent/EA014529B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Способ диагностики сосудистых заболеваний (СЗ), включающий стадию определения наличия или отсутствия по меньшей мере одного полипептидного маркера в образце, где указанный полипептидный маркер выбирают из маркеров 1-526, которые характеризуются определенными значениями молекулярной массы и времени миграции (времени СЕ).
EA200801475A 2005-11-30 2006-11-30 Полипептидные маркеры для диагностики и оценки сосудистых заболеваний EA014529B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005057382 2005-11-30
EP06120879 2006-09-19
PCT/EP2006/069096 WO2007063089A2 (de) 2005-11-30 2006-11-30 Polypeptidmarker zur diagnostik und beurteilung vaskulären erkrankungen

Publications (2)

Publication Number Publication Date
EA200801475A1 true EA200801475A1 (ru) 2009-02-27
EA014529B1 EA014529B1 (ru) 2010-12-30

Family

ID=38092603

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801475A EA014529B1 (ru) 2005-11-30 2006-11-30 Полипептидные маркеры для диагностики и оценки сосудистых заболеваний

Country Status (12)

Country Link
US (2) US20100126861A1 (ru)
EP (1) EP1955075A2 (ru)
JP (1) JP5165580B2 (ru)
KR (1) KR20080074190A (ru)
AU (1) AU2006319138B2 (ru)
BR (1) BRPI0619248A2 (ru)
CA (1) CA2631602A1 (ru)
EA (1) EA014529B1 (ru)
IL (1) IL191605A0 (ru)
NO (1) NO20082394L (ru)
SG (1) SG170009A1 (ru)
WO (1) WO2007063089A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011029954A2 (de) * 2009-09-14 2011-03-17 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0206903B8 (pt) * 2002-12-20 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp método de prognóstico de uma predisposição para o desenvolvimento de hipertensão e lesões no coração, sistema nervoso, sistema vascular ou rins, e uso da isoforma de 90 kda da enzima conversora de angiotensina i no referido método
US20070077614A1 (en) * 2003-04-01 2007-04-05 Wolfert Robert L Uses of lp-pla2 in combination to assess coronary risk
EP1664797B1 (en) * 2003-09-23 2015-11-11 The General Hospital Corporation Screening for preeclampsia

Also Published As

Publication number Publication date
EP1955075A2 (de) 2008-08-13
KR20080074190A (ko) 2008-08-12
AU2006319138A1 (en) 2007-06-07
AU2006319138B2 (en) 2013-05-16
CA2631602A1 (en) 2007-06-07
EA014529B1 (ru) 2010-12-30
SG170009A1 (en) 2011-04-29
JP5165580B2 (ja) 2013-03-21
IL191605A0 (en) 2008-12-29
JP2009521670A (ja) 2009-06-04
WO2007063089A2 (de) 2007-06-07
US20150247865A1 (en) 2015-09-03
US20100126861A1 (en) 2010-05-27
BRPI0619248A2 (pt) 2011-09-20
WO2007063089A3 (de) 2008-01-17
NO20082394L (no) 2008-08-26

Similar Documents

Publication Publication Date Title
ATE441102T1 (de) Verfahren zur detektion von intrazellulären parametern mit lumineszierenden proteinsonden zur selektion von molekülen, die diese parameter ändern kínnen
ATE540319T1 (de) Verfahren für die bestimmung von fk506
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602004019812D1 (de) Marker für neuromyelitis optica
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
ATE439590T1 (de) Verfahren zum selektiven testen von adiponectinmultimeren
WO2007023191A3 (de) Polypeptidmarker zur diagnose von blasenkrebs
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
WO2008110593A3 (de) Verfahren und marker zur diagnose von nierenerkrankungen
DE60321356D1 (de) Verfahren zur diagnostik von eierstock endometriose
WO2011029954A3 (de) Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen
WO2009047280A3 (de) Polypeptidmarker zur diagnose von prostatakrebs
ATE462977T1 (de) Verfahren zum nachweis von autoimmunantikörpern gegen den tsh-rezeptor und neue tsh- rezeptorchimären
EA200801475A1 (ru) Полипептидные маркеры для диагностики и оценки сосудистых заболеваний
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ RU